ask="266.00"
ask_size="300"
average_daily_volume="379826"
bid="21.83"
bid_size="100"
book_value="3.21"
change="+0.37"
change_from_200_day_moving_average="7.71"
change_from_50_day_moving_average="2.50"
change_from_52_week_high="-1.92"
change_From_52_week_low="16.29"
change_in_percent="+1.72%"
close="21.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7150000"
high="22.49"
high_52_weeks="23.75"
last_trade_date="2/22/2017"
last_trade_price="21.83"
last_trade_size="3009"
last_trade_time="4:00pm"
low="21.39"
low_52_weeks="5.54"
market_capitalization="217.27M"
moving_average_200_day="14.12"
moving_average_50_day="19.33"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="21.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+54.62%"
percent_change_from_50_day_moving_average="+12.96%"
percent_change_from_52_week_high="-8.08%"
percent_change_from_52_week_low="+294.04%"
previous_close="21.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.69"
price_per_sales="3778.77"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="424990"
weeks_range_52="5.54 - 23.75"
